Patient support programs rarely fail all at once. More often, patients are lost in the gaps: the days between a prescription and a first dose, the weeks between appointments, or the time between a missed lab and the prescriber finding out.
Each gap may seem small on its own. Together, they can determine whether a patient starts therapy, stays on treatment, and receives the monitoring needed to remain safe.
For pharmaceutical brands, the challenge isn’t always a lack of patient support. It’s knowing where the patient journey is breaking down and which gaps may be putting program performance at risk.
That’s why RxPx developed a four-question self-check to help teams take a step back and identify potential vulnerabilities across the patient journey.
Here are the four questions and why they matter.
1. Getting on therapy: How long does it usually take a new patient to go from prescription to first dose?
A prescription doesn’t always mean treatment has started.
For specialty and complex therapies, patients often navigate multiple steps, including enrollment, consent, benefits verification, access coordination, and site readiness.
When these processes rely on manual follow-ups or disconnected systems, delays can go unnoticed until someone escalates.
The question isn’t just how quickly patients start therapy. It’s whether your team knows where they are in the process and what’s holding them back.
RxPx Accelerate helps streamline the path to treatment, with reported results of patients reaching therapy 13× faster than the industry average.*
2. Staying on therapy: How is support personalized between visits?
Getting patients onto therapy is only the beginning.
Between appointments, patients may experience side effects, changing routines, uncertainty, or personal barriers that aren’t immediately visible to their care team.
While welcome calls, starter kits, and periodic check-ins provide a foundation, they may not be enough to address changing patient needs.
Is your program continuously adapting to each patient’s motivations and barriers, or delivering the same support regardless of their circumstances?
RxPx Elevate combines behavioural intelligence with human support to help patients stay engaged throughout treatment. RxPx has reported adherence rates of 90% across its patient support programs.*
3. Staying safe on therapy: If a required lab is missed or abnormal, how quickly does the prescriber know?
For therapies requiring ongoing safety monitoring, completing a lab test is only part of the process.
Appointments get missed, results are delayed, and critical information can sit in disconnected systems without reaching the right healthcare professional.
Timely identification and follow-up of missed or abnormal results are critical to keeping patients safe on therapy.
Does your program alert prescribers in real time and confirm those alerts have been acknowledged, or does critical information depend on manual follow-up?
RxPx Guardian connects lab monitoring, REMS, and prescriber alerting with nurse-led follow-up for unacknowledged critical alerts. RxPx has proactively monitored more than 1.2 million labs to date.*
4. Connected program: How connected are your hub, sites, labs and support teams?
Even strong individual services can fall short when they operate independently.
Patient support teams, healthcare providers, treatment sites, and labs may each have their own workflows and records. When information is spread across multiple systems and spreadsheets, important details can get lost between handoffs.
A completed task in one system doesn’t necessarily mean the next step has happened.
Are your teams working from one shared patient record and status, or piecing together information across disconnected systems?
A connected program creates visibility across the entire patient journey, helping teams coordinate next steps, identify gaps earlier, and reduce unnecessary handoffs.
Because program performance isn’t just about how well each stage works. It’s about how well they work together.
Where is your program most exposed?
Every patient support program has strengths, but gaps between stages can go unnoticed.
Where Is Your Program Losing Patients? is a quick, four-question self-check designed to help you identify potential gaps in treatment initiation, patient engagement, safety monitoring, and program connectivity.
In under a minute, you’ll receive a rating for each area and discover which RxPx solution could help address your biggest gap.
You can’t address the gaps you can’t see.
Take the 1-minute self-check → https://rxpx.health/patient-gap-survey/
Want to talk it through? Book a 15-minute call with our team at https://rxpx.health/contact/
*As published at rxpx.health, based on RxPx safety monitoring data and the MS case study.
